DUBLIN, June 13, 2018 /PRNewswire/ --
The "Medical Membranes Market by Material (PTFE, PVDF, PP, PSU & PESU), Process Technology (UF, MF, NF), Application (Pharmaceutical Filtration, Hemodialysis, Drug Delivery, IV Infusion & Sterile Filtration), and Region-Global forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The medical membranes market is projected to grow from USD 2.13 Billion in 2017 to USD 3.31 Billion by 2022, at a CAGR of 9.2% during the forecast period.
Medical membranes are increasingly used in the healthcare, pharmaceutical, biotechnology, and life sciences industries. In the medical sector, the choice of membranes depends on various factors that include environments of the proposed application, degree of sterility required, chemical compatibility, biocompatibility, and the degree of hydrophobicity.
The growth of the pharmaceutical and healthcare industries, especially in emerging economies, is a major factor projected to drive the demand for medical membranes. The increasing demand for high purity products is another factor driving the growth of the medical membranes market. APAC and Latin America provide several opportunities for growth of the medical membranes market.
Based on material, the medical membranes market has been segmented into PSU & PESU, PVDF, PTFE, PP, modified acrylics, and others. PVDF and PSU & PESU are the most commonly used medical membranes for the separation of media in pharmaceutical, life sciences, biotechnology, and healthcare sectors.
Based on application, the medical membranes market has been segmented into pharmaceutical filtration, hemodialysis, drug delivery, IV infusion & sterile filtration, and others. The pharmaceutical filtration application segment is projected to lead the medical membranes market during the forecast period. This growth can be attributed to the increase in the production of medicated drugs and expansion of healthcare facilities.
Based on process technology, the medical membranes market has been segmented into ultrafiltration, microfiltration, nanofiltration, and others. The ultrafiltration process technology is projected to lead the medical membranes market from 2017 to 2022. The increasing use of ultrafiltration process technology in pharmaceutical filtration will help increase the market share of ultrafiltration in the medical membranes market.
Based on region, the medical membranes market has been segmented into APAC, North America, Europe, and the Rest of the World. Europe is the leading market for medical membranes. The growth of the medical membranes market in Europe is driven by the increasing aging population (above 65 years), growing End-Stage Renal Disease (ESRD) patient pool, increasing availability of improved diagnosis facilities, and rising incidences of chronic diseases, such as diabetes and hypertension.
The long validation process for medical membranes is a major factor restraining the growth of the medical membranes market. Additionally, manufacturing quality products at affordable prices and increasing the lifespan of medical membranes act as key challenges to the growth of the medical membranes market.
Pall Corporation (US), Asahi Kasei (Japan), 3M (US), Sartorius (Germany), and Merck Millipore (US) are key companies operating in the medical membranes market. Other major manufacturers of medical membranes include GE Healthcare (US), Koch Membrane Systems (US), and W. L. Gore & Associates (US).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Medical Membranes Market Overview, 2017 vs. 2022
4.2 APAC Medical Membranes Market, By Application and Country (2016)
4.3 Medical Membranes Market, By Application
4.4 Medical Membranes Market, By Material
4.5 Medical Membranes Market, By Process Technology
4.6 Medical Membranes Market, By Region
5 Market Overview
5.2 Market Dynamics
188.8.131.52 Increasing Demand for Artificial Organs
184.108.40.206 Requirement for High-Purity Selective Separation
220.127.116.11 Increasing Number of Esrd Patients
18.104.22.168 Preference for Dialysis Procedures Over Renal Transplants
22.214.171.124 Growing Healthcare and Pharmaceutical Industry
126.96.36.199 Long In-Process Validation Process
188.8.131.52 Growing Demand for Medical Membranes in Emerging Economies
184.108.40.206 Lifespan of Membranes
220.127.116.11 Manufacturing Quality Products at Affordable Price
5.3 Value-Chain Analysis
5.3.1 Raw Material Suppliers
5.3.2 Membrane Manufacturers/Formulators
5.3.3 End Users
5.4 Porter's Five Forces Analysis
5.4.1 Threat of New Entrants
5.4.2 Threat of Substitutes
5.4.3 Bargaining Power of Buyers
5.4.4 Bargaining Power of Suppliers
5.4.5 Intensity of Competitive Rivalry
6 Medical Membranes Market, By Material
6.2 Polysulfone (PSU) & Polyether Sulfone (PESU)
6.3 Polyvinylidene Fluoride (PVDF)
6.3.1 Hydrophobic PVDF Membrane
6.3.2 Hydrophilic PVDF Membrane
6.4 Polytetrafluoroethylene (PTFE)
6.5 Polypropylene (PP)
6.6 Modified Acrylics
7 Medical Membranes Market, By Process Technology
7.2 Ultrafiltration (UF)
7.3 Microfiltration (MF)
7.4 Nanofiltration (NF)
8 Medical Membranes Market, By Application
8.2 Pharmaceutical Filtration
8.4 Drug Delivery
8.5 Iv Infusion & Sterile Filtration
9 Medical Membranes Market, By Region
10 Competitive Landscape
10.2 Competitive Scenario
10.2.3 New Product Launches
11 Company Profiles
11.1 Asahi Kasei Corporation
11.2 the 3M Company
11.3 Sartorius Ag
11.4 Merck Millipore (Emd Millipore)
11.5 Pall Corporation
11.6 Ge Healthcare
11.7 Hangzhou Cobetter Filtration Equipment
11.8 Koch Membrane Systems
11.9 Microdyn-Nadir GmbH
11.10 W. L. Gore & Associates, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/n9vg3v/global_medical?w=5
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets